A cross-sectional study of 502 patients found a diffuse hyperechoic kidney medulla pattern in patients with severe gout.

chronic kidney disease estimated glomerular filtration rate gout microcrystalline nephropathy renal ultrasonography

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
01 2021
Historique:
received: 18 02 2020
revised: 18 08 2020
accepted: 27 08 2020
pubmed: 9 9 2020
medline: 22 6 2021
entrez: 8 9 2020
Statut: ppublish

Résumé

We have previously shown that ultrasonography can detect hyperechogenic crystal deposits in the kidney medulla of patients with gout. In this cross-sectional study we investigated the frequency and clinical correlates of hyperechogenic kidney medulla in 502 consecutive primary consultants for gout (ACR/EULAR criteria) at the Vien Gut medical center in Ho Chi Minh City, Vietnam. None of these patients received urate-lowering drugs. Kidney medulla echogenicity on B-mode ultrasonography was compared to that of the kidney cortex. Overall, 36% patients showed a hyperechoic pattern of Malpighi pyramids. On univariate analysis, the pattern was significantly associated with age, estimated gout duration, steroid-dependency, clinical tophi, urate arthropathy, double contour thickness at the scanned joints, coronary heart disease, arterial hypertension, hyperuricemia, proteinuria, leukocyturia, and decreased estimated glomerular filtration rate. On multivariable analysis, the hyperechoic pattern was associated with estimated disease duration, clinical tophi, urate arthropathy, double contour thickness and decreased estimated glomerular filtration rate. No hyperechoic pattern was observed in 515 consecutive consultants without gout. Thus, hyperechoic kidney medulla was frequently demonstrated in Vietnamese patients with tophaceous gout and associated with features of tubulointerstitial nephritis. This finding revives the hypothesis of microcrystalline nephropathy of gout, predominantly seen in untreated gouty patients, which could be an important target for urate-lowering therapy.

Identifiants

pubmed: 32898570
pii: S0085-2538(20)31068-1
doi: 10.1016/j.kint.2020.08.024
pii:
doi:

Substances chimiques

Uric Acid 268B43MJ25

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-226

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Thomas Bardin (T)

French-Vietnamese Research Center on Gout and Chronic Diseases, Vien Gut Medical Center, Ho Chi Minh City, Vietnam; Department of Rheumatology, Hôpital Lariboisière APHP, Paris, France; Université de Paris, INSERM U1132, Paris, France. Electronic address: thomas.bardin@aphp.fr.

Quang D Nguyen (QD)

French-Vietnamese Research Center on Gout and Chronic Diseases, Vien Gut Medical Center, Ho Chi Minh City, Vietnam.

Khoy M Tran (KM)

French-Vietnamese Research Center on Gout and Chronic Diseases, Vien Gut Medical Center, Ho Chi Minh City, Vietnam.

Nghia H Le (NH)

French-Vietnamese Research Center on Gout and Chronic Diseases, Vien Gut Medical Center, Ho Chi Minh City, Vietnam.

Minh D Do (MD)

Center for Molecular Biomedicine, University of Medicine and Pharmacy at Ho Chi Min City, Vietnam.

Pascal Richette (P)

Department of Rheumatology, Hôpital Lariboisière APHP, Paris, France; Université de Paris, INSERM U1132, Paris, France.

Emmanuel Letavernier (E)

Department of Physiology, Hôpital Tenon, APHP, Paris, France; Sorbonne Université and INSERM, UMR S 1155, Hôpital Tenon, Paris, France.

Jean-Michel Correas (JM)

Department of Radiology, Hôpital Necker, APHP, Paris, France; Université de Paris, Paris, France.

Mathieu Resche-Rigon (M)

French-Vietnamese Research Center on Gout and Chronic Diseases, Vien Gut Medical Center, Ho Chi Minh City, Vietnam; Department of Biostatistics, Hôpital Saint Louis, APHP, Paris, France; Université de Paris, UMR U1153 ECSTRA team INERM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH